MEDIA

EVENTS

II FTC – Advanced Therapies and Orphan Drugs

Jul 29, 2009

II FTC – Advanced Therapies and Orphan Drugs

The II Foresight Training Course was organised in collaboration with the Italian Society of Regulatory Activites (SIAR), Consortium for Biological and Pharmacological Evaluations (CVBF), the Task-force in Europe for Drug Development for the Young (TEDDY), the Master in Regulatory Sciences “Gianni Benzi” (University of Pavia), the European Association for Bioindustries (EUROPABIO) and the Middle European Association (MEGRA).

The Course dealt with the newest fields developed in the last years and particularly Advanced Therapies, Orphan Drugs and Paediatric Medicines.

The II FTC represented an opportunity to personally meet some of the members of the EMA, Committee for Advanced Therapies (CAT), Committee for Orphan Medicinal Product (COMP) and Paediatric Committee (PDCO).

Download the agenda here!

Subscribe To Our Newsletter

to keep you up to date on our activities and initiatives

La tua iscrizione non può essere convalidata.
La tua iscrizione è avvenuta correttamente.

We use Brevo as our marketing platform. By clicking below to submit this form, you are aware and accept that the information you have provided will be transferred to Brevo for treatment in accordance with their terms of use
Utilizziamo Brevo come nostra piattaforma di marketing. Cliccando qui sotto per inviare questo modulo, sei consapevole e accetti che le informazioni che hai fornito verranno trasferite a Brevo per il trattamento conformemente alle loro condizioni d'uso

You have Successfully Subscribed!